SCHEMBL374573

SCHEMBL374573

[CH2]CCN1CCCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1219977 0.93 L3MBTL1 (0.46)
SCHEMBL1935110 0.91 L3MBTL1 (0.49)
SCHEMBL2323038 0.87 PIK3CD (0.47)
SCHEMBL261644 0.85 PIK3CD (0.58)
SCHEMBL510427 0.81
SCHEMBL5424673 0.81 PIK3CD (0.54)
SCHEMBL3762707 0.81 L3MBTL1 (0.43)
SCHEMBL9730913 0.79 L3MBTL1 (0.46)
SCHEMBL19514132 0.79 PIK3CD (0.52)
SCHEMBL989008 0.79 PIK3CD (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1055 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023217764-A1 NOX INHIBITORS FOR USE IN THE TREATMENT OF ALPORT SYNDROME CALLIDITAS THERAPEUTICS SUISSE SA (CH) 2023-11-16 WO claimed
CN-112457670-B Hydrophobic polyphenylene sulfide composition with high CTI (comparative tracking index) as well as preparation method and application thereof 金发科技股份有限公司 2022-05-10 CN claimed
CN-110982281-B Blended fluorosilicone rubber composition and preparation method thereof 福建拓烯新材料科技有限公司 2022-03-11 CN claimed
US-20210330678-A1 PAPD5 INHIBITORS AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-10-28 US claimed
EP-3846808-A2 PAPD5 INHIBITORS AND METHODS OF USE THEREOF CHILDREN'S MEDICAL CENTER CORPORATION (US) 2021-07-14 EP claimed
US-20210177811-A1 USE OF NOX INHIBITORS FOR TREATMENT OF CANCER CALLIDITAS THERAPEUTICS SUISSE SA (CH) 2021-06-17 US claimed
EP-3703747-A1 USE OF NOX INHIBITORS FOR TREATMENT OF CANCER GenKyoTex Suisse SA (CH) 2020-09-09 EP claimed
CN-111344013-A Use of NOX inhibitors for the treatment of cancer 吉恩基奥泰克斯瑞士股份有限公司 2020-06-26 CN claimed
CN-110982281-A Blended fluorosilicone rubber composition and preparation method thereof 福建拓烯新材料科技有限公司 2020-04-10 CN claimed
EP-3479843-A1 USE OF NOX INHIBITORS FOR TREATMENT OF CANCER GenKyoTex Suisse SA (CH) 2019-05-08 EP claimed
EP-0274259-B1 New renin-inhibitory oligopeptides, their preparaton and their use SANKYO CO (JP) 1994-02-16 EP claimed
WO-1994002447-A1 HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1994-02-03 WO claimed
WO-1994002446-A1 NATURAL AMINO ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1994-02-03 WO claimed
US-5061725-A COGNITION ACTIVATORS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1991-10-29 US claimed
EP-0225866-B1 QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE Gerot-Pharmazeutika Gesellschaft m.b.H. (AT) 1991-09-25 EP claimed
EP-0408524-A1 (Pyrrolidin-2-on-l-yl) acetamides as enhancers of learning and memory and pharmaceutical compositions comprising same Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1991-01-16 EP claimed
US-4818754-A ANTIALLERGENS BEECHAM GROUP P.L.C. OF BEECHAM HOUSE (GB) 1989-04-04 US claimed
EP-0274259-A2 New renin-inhibitory oligopeptides, their preparaton and their use Sankyo Company Limited (JP) 1988-07-13 EP claimed
EP-0243055-A2 Pyrazolopyridine derivatives, process for their preparation, and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1987-10-28 EP claimed
EP-0230242-A2 Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-07-29 EP claimed